Roche, in consultation with Health Canada, warns that patients being treated with Avastin (bevacizumab) are at risk of serious tracheo-esphogeal fistulas. Avastin a recombinant humanized monoclonal antibody that is directed against the vascular endothelial growth factor (VEGF). It is authorized for ...